ICU · SeaStar Medical Holding Corporation Common Stock
View on chartInsiders & Stakes
| Dow Employees' Pension Plan Trust 10% Owner | ▲ Buy | Open Market | 4,449,841 Shares held | 10/28/2022 | View profile |
| Union Carbide Employees' Pension Plan Trust 10% Owner | ▲ Buy | Open Market | 2,966,555 Shares held | 10/28/2022 | View profile |
| LMFAO Sponsor, LLC 10% Owner | ▲ Buy | Option Exercise | 2,587,500 Shares held | 10/28/2022 | View profile |
| Baron Caryl Interim CFO | ▲ Buy | Grant | 139,872 Shares held | 11/29/2023 | View profile |
| Barnett Rick Director | ▲ Buy | Grant | 86,664 Shares held | 4/12/2024 | View profile |
| Richard D. Russell Director | ▲ Buy | Grant | 60,300 Shares held | 4/12/2024 | View profile |
| Collins Allan Director | ▲ Buy | Grant | 54,343 Shares held | 4/12/2024 | View profile |
| Eric Schlorff Chief Executive Officer | ▲ Buy | Grant | 50,140 Shares held | 7/1/2026 | View profile |
| Rodgers Bruce M. Chairman, CEO and President | ▲ Buy | Grant | 44,515 Shares held | 4/12/2024 | View profile |
| Lobo Andres | ▲ Buy | Grant | 40,300 Shares held | 4/12/2024 | View profile |
| Kevin Chung Chief Medical Officer | ▲ Buy | Grant | 28,021 Shares held | 7/1/2026 | View profile |
| John Neuman | ▲ Buy | Grant | 16,200 Shares held | 7/1/2026 | View profile |
| Van Heel Kenneth Director | ▲ Buy | Grant | 11,940 Shares held | 7/1/2026 | View profile |
| Jennifer A. Baird | ▲ Buy | Grant | 10,620 Shares held | 7/1/2026 | View profile |
| David A. Green Chief Financial Officer | ▲ Buy | Grant | 10,323 Shares held | 8/30/2024 | View profile |
| Bradford K. Towne Principal Accounting Officer | ▲ Buy | Grant | 9,050 Shares held | 2/6/2026 | View profile |
| Bernadette N. Vincent | ▲ Buy | Grant | 8,200 Shares held | 7/1/2026 | View profile |
| Michael Messinger Chief Financial Officer | ▲ Buy | Open Market | 2,500 Shares held | 8/18/2026 | View profile |
Transaction History
| Michael Messinger | ▲ Buy | Open Market | 750 | $2K | 8/18/2026 |
| Kevin Chung | ▲ Buy | Grant | 7,202 | $0 | 7/1/2026 |
| Bernadette N. Vincent | ▲ Buy | Grant | 4,000 | $0 | 7/1/2026 |
| Eric Schlorff | ▲ Buy | Grant | 10,288 | $0 | 7/1/2026 |
| John Neuman | ▲ Buy | Grant | 4,000 | $0 | 7/1/2026 |
| Van Heel Kenneth | ▲ Buy | Grant | 4,000 | $0 | 7/1/2026 |
| Jennifer A. Baird | ▲ Buy | Grant | 4,000 | $0 | 7/1/2026 |
| Jennifer A. Baird | ▲ Buy | Grant | 3,000 | $0 | 2/6/2026 |
| Kevin Chung | ▲ Buy | Grant | 15,000 | $0 | 2/6/2026 |
| Bradford K. Towne | ▲ Buy | Grant | 7,500 | $0 | 2/6/2026 |
| Eric Schlorff | ▲ Buy | Grant | 30,000 | $0 | 2/6/2026 |
| Bernadette N. Vincent | ▲ Buy | Grant | 3,000 | $0 | 2/6/2026 |
| Van Heel Kenneth | ▲ Buy | Grant | 3,000 | $0 | 2/6/2026 |
| John Neuman | ▲ Buy | Grant | 3,000 | $0 | 2/6/2026 |
| Jennifer A. Baird | ▲ Buy | Open Market | 4,200 | $987 | 12/19/2025 |
| Michael Messinger | ▲ Buy | Open Market | 14,500 | $5K | 12/9/2025 |
| Van Heel Kenneth | ▲ Buy | Open Market | 10,000 | $9K | 8/27/2025 |
| Van Heel Kenneth | ▲ Buy | Open Market | 25,000 | $22K | 8/26/2025 |
| Kevin Chung | ▲ Buy | Open Market | 10,000 | $8K | 8/22/2025 |
| Jennifer A. Baird | ▲ Buy | Grant | 4,000 | $0 | 7/10/2025 |
| Van Heel Kenneth | ▲ Buy | Grant | 4,000 | $0 | 7/10/2025 |
| Bernadette N. Vincent | ▲ Buy | Grant | 4,000 | $0 | 7/10/2025 |
| John Neuman | ▲ Buy | Grant | 4,000 | $0 | 7/10/2025 |
| Kevin Chung | ▲ Buy | Option Exercise | 5,000 | $0 | 7/1/2025 |
| Eric Schlorff | ▲ Buy | Option Exercise | 21,667 | $0 | 7/1/2025 |
| Jennifer A. Baird | ▲ Buy | Open Market | 10,000 | $4K | 6/30/2025 |
| John Neuman | ▲ Buy | Open Market | 40,000 | $14K | 6/24/2025 |
| John Neuman | ▲ Buy | Option Exercise | 2,667 | $0 | 6/4/2025 |
| Bernadette N. Vincent | ▲ Buy | Option Exercise | 2,667 | $0 | 6/4/2025 |
| Van Heel Kenneth | ▲ Buy | Option Exercise | 4,000 | $0 | 6/4/2025 |
| Jennifer A. Baird | ▲ Buy | Option Exercise | 2,667 | $0 | 6/4/2025 |
| Jennifer A. Baird | ▲ Buy | Open Market | 10,000 | $13K | 5/20/2025 |
| Kevin Chung | ▲ Buy | Open Market | 4,500 | $6K | 5/20/2025 |
| John Neuman | ▲ Buy | Open Market | 10,000 | $20K | 12/11/2024 |
| Kevin Chung | ▲ Buy | Open Market | 4,250 | $8K | 11/18/2024 |
| Kevin Chung | ▲ Buy | Open Market | 1,000 | $4K | 9/30/2024 |
| David A. Green | ▲ Buy | Grant | 8,100 | $0 | 8/30/2024 |
| John Neuman | ▲ Buy | Open Market | 10,000 | $52K | 8/15/2024 |
| John Neuman | ▲ Buy | Open Market | 10,000 | $44K | 6/17/2024 |
| John Neuman | ▲ Buy | Open Market | 10,000 | $37K | 6/14/2024 |
| David A. Green | ▲ Buy | Grant | 2,223 | $0 | 4/18/2024 |
| David A. Green | ▲ Buy | Grant | 752,500 | $0 | 4/12/2024 |
| Richard D. Russell | ▲ Buy | Grant | 32,322 | $0 | 4/12/2024 |
| Lobo Andres | ▲ Buy | Grant | 32,322 | $0 | 4/12/2024 |
| Barnett Rick | ▲ Buy | Grant | 70,264 | $0 | 4/12/2024 |
| Van Heel Kenneth | ▲ Buy | Grant | 43,564 | $0 | 4/12/2024 |
| Collins Allan | ▲ Buy | Grant | 37,943 | $0 | 4/12/2024 |
| Rodgers Bruce M. | ▲ Buy | Grant | 36,537 | $0 | 4/12/2024 |
| Eric Schlorff | ▲ Buy | Grant | 60,248 | $0 | 11/29/2023 |
| Kevin Chung | ▲ Buy | Grant | 63,422 | $0 | 11/29/2023 |
| Baron Caryl | ▲ Buy | Grant | 20,293 | $0 | 11/29/2023 |
| Van Heel Kenneth | ▲ Buy | Open Market | 100,000 | $40K | 11/22/2023 |
| Baron Caryl | ▼ Sell | Other | 15,070 | $0 | 9/22/2023 |
| Baron Caryl | ▲ Buy | Grant | 4,110 | $0 | 9/15/2023 |
| Kevin Chung | ▲ Buy | Grant | 34,257 | $0 | 9/15/2023 |
| Eric Schlorff | ▲ Buy | Grant | 41,109 | $0 | 9/15/2023 |
| Eric Schlorff | ▲ Buy | Grant | 35,178 | $0 | 8/31/2023 |
| Baron Caryl | ▲ Buy | Grant | 3,374 | $0 | 8/31/2023 |
| Kevin Chung | ▲ Buy | Grant | 35,178 | $0 | 8/31/2023 |
| Eric Schlorff | ▲ Buy | Grant | 21,176 | $0 | 8/15/2023 |
| Baron Caryl | ▲ Buy | Grant | 2,031 | $0 | 8/15/2023 |
| Kevin Chung | ▲ Buy | Grant | 16,930 | $0 | 8/15/2023 |
| Eric Schlorff | ▲ Buy | Grant | 417,386 | $0 | 6/23/2023 |
| Baron Caryl | ▲ Buy | Grant | 56,869 | $0 | 6/9/2023 |
| Baron Caryl | ▼ Sell | Tax Withholding | 15,070 | $8K | 6/9/2023 |
| Kevin Chung | ▲ Buy | Open Market | 5,093 | $2K | 5/30/2023 |
| Kevin Chung | ▲ Buy | Open Market | 4,000 | $2K | 5/30/2023 |
| Kevin Chung | ▲ Buy | Open Market | 2,300 | $1K | 5/30/2023 |
| Kevin Chung | ▲ Buy | Open Market | 1,150 | $546 | 5/30/2023 |
| Richard D. Russell | ▲ Buy | Open Market | 20,000 | $10K | 5/25/2023 |
| Kevin Chung | ▲ Buy | Open Market | 7,500 | $5K | 5/18/2023 |
| Rodgers Bruce M. | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 |
| Baron Caryl | ▲ Buy | Grant | 11,080 | $0 | 4/6/2023 |
| Eric Schlorff | ▲ Buy | Grant | 66,483 | $0 | 4/6/2023 |
| Collins Allan | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 |
| Van Heel Kenneth | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 |
| Barnett Rick | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 |
| Lobo Andres | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 |
| Richard D. Russell | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 |
| Van Heel Kenneth | ▲ Buy | Grant | 8,422 | $0 | 10/28/2022 |
| Collins Allan | ▲ Buy | Grant | 8,422 | $0 | 10/28/2022 |
| Eric Schlorff | ▲ Buy | Grant | 198,530 | $0 | 10/28/2022 |
| LMFAO Sponsor, LLC | ▲ Buy | Option Exercise | 2,587,500 | $0 | 10/28/2022 |
| Barnett Rick | ▲ Buy | Grant | 8,422 | $0 | 10/28/2022 |
| Union Carbide Employees' Pension Plan Trust | ▲ Buy | Grant | 2,766,555 | — | 10/28/2022 |
| Union Carbide Employees' Pension Plan Trust | ▲ Buy | Open Market | 200,000 | — | 10/28/2022 |
| Dow Employees' Pension Plan Trust | ▲ Buy | Grant | 4,149,841 | — | 10/28/2022 |
| Dow Employees' Pension Plan Trust | ▲ Buy | Open Market | 300,000 | — | 10/28/2022 |
| Baron Caryl | ▲ Buy | Grant | 42,112 | $0 | 10/28/2022 |
| Kevin Chung | ▲ Buy | Grant | 44,322 | $0 | 4/6/2022 |
| Kevin Chung | ▲ Buy | Open Market | 3,760 | $7K | 4/5/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SeaStar Medical Adds ICD‑10‑PCS Codes for AKI Therapy
SeaStar Medical has released new ICD‑10‑PCS codes for its SCD therapy used in acute kidney injury. The codes allow hospitals to bill for the treatment, which could broaden usage. Earlier this week the company’s Chief Medical Officer, Kevin Chung, will speak at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium, highlighting the therapy’s pediatric applications. The company’s shares are trading near a key support level and have shown a recent volume spike.
SeaStar Medical Adds ICD‑10‑PCS Codes for AKI Therapy. SeaStar Medical has released new ICD‑10‑PCS codes for its SCD therapy used in acute kidney injury. The codes allow hospitals to bill for the treatment, which could broaden usage. Earlier this week the company’s Chief Medical Officer, Kevin Chung, will speak at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium, highlighting the therapy’s pediatric applications. The company’s shares are trading near a key support level and have shown a recent volume spike.